EMA Receives application for Conditional Marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19
Synopsis: EMA has started evaluating an application for a conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 and ritonavir). The…